Nuvigil Labeling Will Likely Include Safety Information From Sparlon Clinical Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon’s follow-on product gets “approvable” letter as FDA considers common labeling for Provigil, Sparlon and Nuvigil.